carbon monoxide has been researched along with Limited Scleroderma in 5 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated in systemic sclerosis (SSc) patients the T cell homeostasis and its relationship with the clinical course of the disease." | 1.36 | Analyses of T cell phenotype and function reveal an altered T cell homeostasis in systemic sclerosis. Correlations with disease severity and phenotypes. ( Gambardella, L; Giammarioli, AM; Giovannetti, A; Malorni, W; Maselli, A; Palange, P; Paoletti, P; Pierdominici, M; Pisarri, S; Renzi, C; Rosato, E; Salsano, F, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwata, Y | 1 |
| Yoshizaki, A | 1 |
| Ogawa, F | 2 |
| Komura, K | 1 |
| Hara, T | 2 |
| Muroi, E | 2 |
| Takenaka, M | 1 |
| Shimizu, K | 2 |
| Hasegawa, M | 2 |
| Fujimoto, M | 1 |
| Takehara, K | 2 |
| Sato, S | 3 |
| Giovannetti, A | 1 |
| Rosato, E | 1 |
| Renzi, C | 1 |
| Maselli, A | 1 |
| Gambardella, L | 1 |
| Giammarioli, AM | 1 |
| Palange, P | 1 |
| Paoletti, P | 1 |
| Pisarri, S | 1 |
| Salsano, F | 1 |
| Malorni, W | 1 |
| Pierdominici, M | 1 |
| Aozasa, N | 1 |
| Asano, Y | 1 |
| Akamata, K | 1 |
| Noda, S | 1 |
| Masui, Y | 1 |
| Tamaki, Z | 1 |
| Tada, Y | 1 |
| Sugaya, M | 1 |
| Kadono, T | 1 |
| Launay, D | 1 |
| Mouthon, L | 1 |
| Hachulla, E | 1 |
| Pagnoux, C | 1 |
| de Groote, P | 1 |
| Remy-Jardin, M | 1 |
| Matran, R | 1 |
| Lambert, M | 1 |
| Queyrel, V | 1 |
| Morell-Dubois, S | 1 |
| Guillevin, L | 1 |
| Hatron, PY | 1 |
5 other studies available for carbon monoxide and Limited Scleroderma
| Article | Year |
|---|---|
Increased serum pentraxin 3 in patients with systemic sclerosis.
Topics: Acute-Phase Proteins; Biomarkers; C-Reactive Protein; Carbon Monoxide; Cells, Cultured; Enzyme-Linke | 2009 |
Analyses of T cell phenotype and function reveal an altered T cell homeostasis in systemic sclerosis. Correlations with disease severity and phenotypes.
Topics: Adult; Aged; Aged, 80 and over; Aging; Apoptosis; Carbon Monoxide; CD4 Lymphocyte Count; Cell Prolif | 2010 |
Clinical significance of serum levels of secretory leukocyte protease inhibitor in patients with systemic sclerosis.
Topics: Biomarkers; Carbon Monoxide; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lung; Lung Diseases, | 2012 |
Serum levels of 8-isoprostane, a marker of oxidative stress, are elevated in patients with systemic sclerosis.
Topics: Adult; Aged; Biomarkers; Carbon Monoxide; Dinoprost; Female; Humans; Male; Middle Aged; Oxidative St | 2006 |
Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
Topics: Adult; Carbon Monoxide; Comorbidity; Dyspnea; Female; Humans; Hypertension, Pulmonary; Lung Diseases | 2007 |